(UroToday.com) Inguinal lymph node dissection is a core component in the management of penile squamous cell carcinoma with involvement, or a high risk of involvement, of the inguinal lymph nodes. Available information is lacking regarding the exact incidence, site, and timing of recurrence after inguinal lymph node dissection. Such knowledge would be critically useful to inform evidence-based post-inguinal lymph node dissection surveillance protocols, as well as patient counseling. Dr. Nicholas Chakiryan from the Moffitt Cancer provided a discussion at the Society of Urologic Oncology (SUO) virtual 2020 annual meeting regarding detailed data on incidence, site, and timing of recurrence after inguinal lymph node dissection in a large multi-institutional international cohort.